Meury William
SEC CIK 1536778 · EDGAR
BoughtSold
Most active insiders at INCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoppenot Herve | Dir | — | $19.77M |
| 2 | CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| 3 | Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| 4 | Mayes Patrick A | EVP, CSO | — | $6.56M |
| 5 | Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| 6 | Clancy Paul J | Dir | — | $1.42M |
| 7 | Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| 8 | Tray Thomas | Principal Accounting Off | — | $879.0K |
| 9 | Denton Sheila A. | EVP, GC | — | $465.2K |
| 10 | Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
| 16 | Meury William | CEO, Dir, Pres | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-20 16:07 | 2026-07-16 | INCY | Incyte | Meury William | CEO, Dir | A - Grant | $0.00 | +26.8K | 183.1K | +17% | $0 |
| 2026-07-07 16:09 | 2026-07-02 | INCY | Incyte | Meury William | CEO, Dir, Pres | F - Tax | $116.86 | -4,779 | 156.3K | -3% | -$558.5K | |
| 2026-04-17 16:13 | 2026-04-15 | INCY | Incyte | Meury William | CEO, Dir, Pres | M - OptEx | $0.00 | +125.0K | 161.1K | +346% | $0 | |
| D | 2025-07-02 | 2025-07-02 | INCY | Incyte | Meury William | CEO, Dir, Pres | A - Grant | $0.00 | +36.1K | 36.1K | New | $0 |
| 2025-02-07 | 2025-02-05 | SNDX | Syndax Pharmaceuticals Inc | Meury William | Dir | A - Grant | $0.00 | +25.0K | 90.0K | +38% | $0 | |
| 2024-02-09 | 2024-02-07 | SNDX | Syndax Pharmaceuticals Inc | Meury William | Dir | A - Grant | $0.00 | +17.0K | 65.0K | +35% | $0 | |
| DMT | 2023-08-03 | 2023-08-02 | SNDX | Syndax Pharmaceuticals Inc | Meury William | Dir | S - Sale+OE | $20.46 | -83.0K | 48.0K | -63% | -$1.70M |
| DMT | 2023-08-03 | 2023-08-02 | SNDX | Syndax Pharmaceuticals Inc | Meury William | Dir | M - OptEx | $8.02 | +83.0K | 72.0K | New | +$665.2K |
| 2023-02-03 | 2023-02-02 | SNDX | Syndax Pharmaceuticals Inc | Meury William | Dir | A - Grant | $0.00 | +16.0K | 48.0K | +50% | $0 | |
| 2022-02-03 | 2022-02-02 | SNDX | Syndax Pharmaceuticals Inc | Meury William | Dir | A - Grant | $0.00 | +16.0K | 32.0K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations